INSIGHTS ON LIQUID DOSE MANUFACTURING

• Service Solutions Designed To Help You Gain Speed To Clinic And Market

  Discover how speed, cost, and regulatory acceptance impact drug manufacturing, as well as learn about aseptic filling challenges and how innovative services can enhance your efficiency and compliance.

• Thermo Fisher Scientific Large Volume Liquid Expansion

  Take an insightful look into the expansion of the large volume liquids manufacturing site at the Grand Island facility, highlighting the various stages of the manufacturing process and the capabilities it offers to support the bioprocessing industry.

• Isolated GENiSYS C Fill-Finish System: Available For Quick Delivery

  Accelerate your parenteral drug production with a fully integrated, isolator-based fill-finish system. Compact design, rapid delivery, and maximum yield for agile drug development.

• Sterile Injectables: Why Innovation Matters More Than Ever

  New technologies and regulatory changes are shaping safer, more efficient filling processes. Discover why innovation is key to protecting patients and advancing therapies.

• Isolators For Pharmacy Compounding – Time For Change?

  3/14/2025

  Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.

• Navigating The New USP Chapter <382> For Elastomeric Closures

  6/24/2025

  Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.

• Compressed Gas Systems In Aseptic Manufacturing

  10/18/2024

  Learn about compressed gas systems and why effectively identifying and managing the risks associated with these systems is critical for maintaining product quality and ensuring compliance with GMP.

• Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables

  10/20/2025

  Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.

• CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever

  12/29/2025

  As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.